Back to results
US 10,537,523 B2Granted
Oral suspension comprising telmisartan
OwnerDetlef Mohr, Stefan Lehnerinventors
Life of this patent
Estimating the term…
Abstract
A drinkable pharmaceutical solution includes telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof, where the telmisartan has a concentration of 1 to 10 mg/ml within the drinkable pharmaceutical solution, and the drinkable pharmaceutical solution has a pH of 10.
Claims12
A drinkable pharmaceutical solution comprising:
- telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof, wherein the telmisartan is present in a concentration of 1 to 10 mg/ml within the drinkable pharmaceutical solution;
- sodium hydroxide;
- one or more sugar alcohols selected from the group consisting of maltitol, xylitol, sorbitol, and mannitol, wherein the one or more sugar alcohols have a total concentration of 40 wt. % to 70 wt. % within the drinkable pharmaceutical solution and a maximum content of 2000 ppm of reducing sugar before addition to the drinkable pharmaceutical solution;
- optionally saccharin-Na;
- optionally benzalkonium chloride;
- and
- water;
- wherein the drinkable pharmaceutical solution has a pH of 10.
5 more elements
Dependencies are inferred from the claim text.